Delivery Order SPE2DB24D1205-SPE2DB25FDARL
- Not listed
- The Defense Logistics Agency awarded a $15,047.95 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $30,140.34 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV prevention and treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $2,842.20 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 18, 2025, with completion expected by September 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, representing a...
- The Defense Logistics Agency awarded a delivery order valued at $5,900.78 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 8, 2025, with a completion date of August 11, 2025. This competitively awarded, non-set-aside firm fixed price delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention, reflecting the Department of Defense's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,120.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 10, 2025, with completion targeted for September 11, 2025. This firm fixed price delivery order was awarded on a competitive basis with no set-aside designation. The contract performs in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,762.29 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 29, 2025, with completion targeted for September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $18,513.98 delivery order contract to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 5, 2025, with completion scheduled for September 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 units, valued at $28,822.69. This firm fixed-price delivery order, which is not set-aside, was awarded on July 8, 2025, with an ultimate completion date of July 9, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an HIV prevention and treatment medication, reflecting the company's role as a...
- The Defense Logistics Agency awarded a $27,345.32 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price delivery order represents a non-set-aside competitive procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV treatment and prevention, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $36,331.88 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (quantity: 30 units) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement of pharmaceutical supplies for federal medical needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDARLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,810.96 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 18, 2025, with completion scheduled for September 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. DESCOVY is an HIV prevention and treatment medication, reflecting the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains to support federal defense and healthcare missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 9/18/25 |